New Key Statistics Module, Z-Score and F-Score
NAS:RYTM Key Ratios
Market Cap $ M | 2,405.62 |
Enterprise Value $ M | 2,071.49 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 13.97 |
Price/Sales | 28.49 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 77.00 |
EPS (TTM) $ | -3.20 |
Beneish M-Score | -1.46 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 1.60 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.18 |
EV-to-EBITDA | -12.31 |
PEG | -- |
Shares Outstanding M | 60.14 |
Net Margin (%) | -238.52 |
Operating Margin % | -238.10 |
Pre-tax Margin (%) | -237.79 |
Quick Ratio | 5.43 |
Current Ratio | 5.58 |
ROA % (ttm) | -53.53 |
ROE % (ttm) | -89.34 |
ROIC % (ttm) | -581.18 |
Dividend Yield % | -- |
Altman Z-Score | 4.33 |
RYTM Number of Guru Trades
RYTM Volume of Guru Trades
Gurus Latest Trades with NAS:RYTM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RYTM is held by these investors
Total 2
Rhythm Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:RYTM
Total 0- 1